Antibiotic prophylaxes in laser resurfacing patients

Dermatologic Surgery

Volumn 26, Issue 7, 2000, Pages 695-697

  Friedman, Paul M ^a   Geronemus, Roy G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; DICLOXACILLIN; MACROLIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; DRUG INDICATION; HUMAN; INFECTION RATE; PATIENT EDUCATION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RISK FACTOR; SHORT SURVEY; SKIN SURGERY; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; LASER SURGERY; POSTOPERATIVE COMPLICATIONS; RHYTIDOPLASTY;

EID: 0033912853     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2000.00090.x     Document Type: Article

References (22)

1. 1 Duke D & Grevelink JM. Care before and after laser skin resurfacing: a survey and review of the literature. Dermatol Surg 1998 ; 24: 201 6.
2. 2 Ross EV, Amesbury EC, Barile A, Proctor‐Shipman L, Feldman BD. Incidence of postoperative infection or positive culture after laser resurfacing: a pilot study, a case report, and a proposal for a rational approach to antibiotic prophylaxis. J Am Acad Dermatol 1998 ; 39: 975 81.
3. 3 Sripachya‐Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997 ; 23: 527 36.
4. 4 Phillips LG, Heggers JP, Robson MC, Boertman JA, Meltzer T, Smith DJ. The effect of endogenous skin bacteria on burn wound infection. Ann Plast Surg 1989 ; 23: 35 8.
5. 5 Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejci‐Papa N. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999 ; 40: 77 84.
6. 6 Waldorf HA, Kauvar ANB, Grossman MC, Geronemus RG. Skin resurfacing of fine to deep rhytides using a char‐free carbon dioxide laser in 47 patients. Dermatol Surg 1995 ; 21: 940 6.
7. 7 Bernstein LJ, Kauvar ANB, Grossman MC, Geronemus RG. The short‐ and long‐term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997 ; 23: 519 25.
8. 8 Geronemus RG, Alster TS, Brandt FS, Dover JS, Fitzpatrick RE. Tabletalk: Common questions about laser resurfacing. Dermatol Surg 1998 ; 24: 121 30.
9. 9 Lowe NJ, Lask G, Griffin ME. Laser skin resurfacing: pre and post treatment guidelines. Dermatol Surg 1995 ; 21: 1017 9.
10. 10 Weinstein C, Ramirez O, Pozner J. Postoperative care following carbon dioxide laser resurfacing: avoiding pitfalls. Dermatol Surg 1998 ; 24: 51 6.
11. 11 Christian MM, Behroozan DS, Moy RL. Delayed infections following full‐face CO 2 laser resurfacing and occlusive dressing use. Dermatol Surg 2000 ; 26: 32 6.
12. 12 Kilmer S. How to minimize complications of laser resurfacing. Skin Aging 2000 ; 46–9.
13. 13 Grekin RC. Cutaneous CO 2 laser resurfacing infection rate with and without prophylactic antibiotics [commentary]. Dermatol Surg 1999 ; 25: 51 6.
14. 14 Walia S & Alster TS. Cutaneous CO 2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999 ; 25: 857 61.
15. 15 Munster AM. Immunologic response to trauma and burns: an overview. AM J Med 1984 ; 76: 142 5.
16. 16 Geronemus RG. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin [commentary]. Dermatol Surg 1997 ; 23: 535 6.
17. 17 Bellman B, Brandt FS, Holtmann M, Bebell WR. Infection with methicillin‐resistant staphylococcus aureus after carbon dioxide resurfacing of the face. Dermatol Surg 1998 ; 24: 279 82.
18. 18 Palmer D, Pett S, Akl B. Bacterial wound colonization after broad spectrum versus narrow‐spectrum antibiotics. Ann Thorac Surg 1995 ; 59: 626 31.
19. 19 Haas AF & Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995 ; 32: 155 76.
20. 20 Weinstein HJ. The relationship between the nasal staphylococcal carrier state and the incidence of post‐operative complications. N Engl J Med 1959 ; 260: 1303 6.
21. 21 McNeill IF, Porter IA, Green CA. Staphylococcal infection in a surgical ward: a three‐month study. Br Med J 1961 ; 2: 798 802.
22. 22 Horwitz RI & Feinstein AR. Improved observational method for studying therapeutic efficacy: suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. JAMA 1981 ; 246: 2455 9.